193 related articles for article (PubMed ID: 24651368)
21. Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.
Kelly JL; Novak AJ; Fredericksen ZS; Liebow M; Ansell SM; Dogan A; Wang AH; Witzig TE; Call TG; Kay NE; Habermann TM; Slager SL; Cerhan JR
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2847-58. PubMed ID: 20855536
[TBL] [Abstract][Full Text] [Related]
22. The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma.
LeBrun DP; Ngan BY; Weiss LM; Huie P; Warnke RA; Cleary ML
Blood; 1994 Jan; 83(1):223-30. PubMed ID: 8274737
[TBL] [Abstract][Full Text] [Related]
23. A transcribed pseudogene of MYLK promotes cell proliferation.
Han YJ; Ma SF; Yourek G; Park YD; Garcia JG
FASEB J; 2011 Jul; 25(7):2305-12. PubMed ID: 21441351
[TBL] [Abstract][Full Text] [Related]
24. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.
Kan T; Sato F; Ito T; Matsumura N; David S; Cheng Y; Agarwal R; Paun BC; Jin Z; Olaru AV; Selaru FM; Hamilton JP; Yang J; Abraham JM; Mori Y; Meltzer SJ
Gastroenterology; 2009 May; 136(5):1689-700. PubMed ID: 19422085
[TBL] [Abstract][Full Text] [Related]
25. P68 RNA helicase promotes invasion of glioma cells through negatively regulating DUSP5.
Wang R; Bao HB; Du WZ; Chen XF; Liu HL; Han DY; Wang LG; Wu JN; Wang CL; Yang MC; Liu ZW; Zhang N; Teng L
Cancer Sci; 2019 Jan; 110(1):107-117. PubMed ID: 30387548
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
27. bcl-2 expression in Hodgkin's disease. Correlation with the t(14;18) translocation and Epstein-Barr virus.
Bhagat SK; Medeiros LJ; Weiss LM; Wang J; Raffeld M; Stetler-Stevenson M
Am J Clin Pathol; 1993 May; 99(5):604-8. PubMed ID: 8388163
[TBL] [Abstract][Full Text] [Related]
28. Frequent expression of the cell death-inducing gene Bax in Reed-Sternberg cells of Hodgkin's disease.
Brousset P; Benharroch D; Krajewski S; Laurent G; Meggetto F; Rigal-Huguet F; Gopas J; Prinsloo I; Pris J; Delsol G; Reed JC; Schlaifer D
Blood; 1996 Mar; 87(6):2470-5. PubMed ID: 8630413
[TBL] [Abstract][Full Text] [Related]
29. Cell cycle arrest and apoptosis by expression of a novel TPIP (TPIP-C2) cDNA encoding a C2-domain in HEK-293 cells.
Mishra RR; Chaudhary JK; Rath PC
Mol Biol Rep; 2012 Jul; 39(7):7389-402. PubMed ID: 22311048
[TBL] [Abstract][Full Text] [Related]
30. Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.
Nagel S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Oncotarget; 2015 Nov; 6(37):40112-26. PubMed ID: 26473286
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis.
Murray PG; Fan Y; Davies G; Ying J; Geng H; Ng KM; Li H; Gao Z; Wei W; Bose S; Anderton J; Kapatai G; Reynolds G; Ito A; Marafioti T; Woodman CB; Ambinder R; Tao Q
Am J Pathol; 2010 Sep; 177(3):1480-90. PubMed ID: 20709797
[TBL] [Abstract][Full Text] [Related]
32. Cloning and characterization of the promoter regions from the parent and paralogous creatine transporter genes.
Ndika JD; Lusink V; Beaubrun C; Kanhai W; Martinez-Munoz C; Jakobs C; Salomons GS
Gene; 2014 Jan; 533(2):488-93. PubMed ID: 24144841
[TBL] [Abstract][Full Text] [Related]
33. Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
Wrone-Smith T; Izban KF; Ergin M; Cosar EF; Hsi ED; Alkan S
Exp Hematol; 2001 May; 29(5):572-81. PubMed ID: 11376869
[TBL] [Abstract][Full Text] [Related]
34. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
[TBL] [Abstract][Full Text] [Related]
35. The competing endogenous RNA network of CYP4Z1 and pseudogene CYP4Z2P exerts an anti-apoptotic function in breast cancer.
Li C; Zheng L; Xin Y; Tan Z; Zhang Y; Meng X; Wang Z; Xi T
FEBS Lett; 2017 Apr; 591(7):991-1000. PubMed ID: 28236635
[TBL] [Abstract][Full Text] [Related]
36. Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.
Schwering I; Bräuninger A; Distler V; Jesdinsky J; Diehl V; Hansmann ML; Rajewsky K; Küppers R
Mol Med; 2003; 9(3-4):85-95. PubMed ID: 12865944
[TBL] [Abstract][Full Text] [Related]
37. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
[TBL] [Abstract][Full Text] [Related]
38. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Schwering I; Bräuninger A; Klein U; Jungnickel B; Tinguely M; Diehl V; Hansmann ML; Dalla-Favera R; Rajewsky K; Küppers R
Blood; 2003 Feb; 101(4):1505-12. PubMed ID: 12393731
[TBL] [Abstract][Full Text] [Related]
39. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma.
Murray PG; Qiu GH; Fu L; Waites ER; Srivastava G; Heys D; Agathanggelou A; Latif F; Grundy RG; Mann JR; Starczynski J; Crocker J; Parkes SE; Ambinder RF; Young LS; Tao Q
Oncogene; 2004 Feb; 23(6):1326-31. PubMed ID: 14961078
[TBL] [Abstract][Full Text] [Related]
40. The human ABC transporter pseudogene family: Evidence for transcription and gene-pseudogene interference.
Piehler AP; Hellum M; Wenzel JJ; Kaminski E; Haug KB; Kierulf P; Kaminski WE
BMC Genomics; 2008 Apr; 9():165. PubMed ID: 18405356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
